Novartis pauses autoimmune cell therapy trials after three deaths
Novartis paused eight late-August clinical trials of an experimental cell therapy for autoimmune and neurological disorders after three patients died from a severe immune response, according to WSJ.
By Xavier MartinezNovartis paused eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders in late August, after three patients died.The Swiss pharmaceutical company temporarily halted the studies after learning of three fatal cases of a severe immune respons…